Translational Cancer Research
Country
Hong Kong
Asiatic Region
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Radiology, Nuclear Medicine and Imaging
Q2
└
Oncology
Q3
└
Cancer Research
Q4
Publisher
SJR 2025
0.524
Q2
SJR Score
H-Index
47
Citations / Doc (2yr)
1.93
Total Docs. (latest)
651
Total Citations (3yr)
2,478
Publication type
Journals
ISSN
22196803, 2218676X
Coverage
2012-2026
Journal Rank
#11,374
Subject Categories
Radiology, Nuclear Medicine and Imaging
Q2
Oncology
Q3
Cancer Research
Q4
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 651 |
| Total Docs. (3 years) | 1,273 |
| Total Refs. | 25,661 |
| Total Citations (3 years) | 2,478 |
| Citable Docs. (3 years) | 1,168 |
| Citations / Doc. (2 years) | 1.93 |
| Ref. / Doc. | 39.42 |
| % Female | 42.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Translational Cancer Research?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Translational Cancer Research has an SJR of 0.524 and is ranked Q2.
What is the SJR and quartile of Translational Cancer Research?
Translational Cancer Research has an SJR (SCImago Journal Rank) of 0.524 and its best quartile is Q2.
What is the H-index of Translational Cancer Research?
The H-index of Translational Cancer Research is 47, meaning 47 of its articles have each been cited at least 47 times.
Is Translational Cancer Research indexed in Scopus?
Yes. Translational Cancer Research is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.